BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | A205954 | ALVOGEN INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
INDIVIOR INC. et al v. ALVOGEN PINE BROOK LLC 1 patentANDA 205954buprenorphine hydrochloride and naloxone hydrochloride | D.N.J. | 2018-04-03 | Terminated 2018-05-29 | — |
INDIVIOR INC. et al v. ALVOGEN PINE BROOK, INC. 1 patentANDA 205954buprenorphine hydrochloride and naloxone hydrochloride | D.N.J. | 2017-09-14 | Terminated 2023-11-09 | — |
Indivior Inc. et al v. Alvogen Pine Brook LLC 5 patentsANDA 205954buprenorphine hydrochloride and naloxone hydrochloride | D. Del. | 2015-06-10 | Terminated 2018-05-08 | — |
Reckitt Benckiser Pharmaceuticals Inc. et al v. Alvogen Pine Brook Inc 3 patentsANDA 205954buprenorphine hydrochloride and naloxone hydrochloride | D. Del. | 2013-12-06 | Terminated 2014-05-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.